Ironwood Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Ironwood Pharmaceuticals, Inc. (IRWD) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.090.090.660.620.360.180.17
Cash & Short-Term Investments0.090.090.660.620.360.180.17
Accounts Receivable0.080.130.120.110.120.120.08
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.100.010.070.050.00
Total Current Assets0.180.230.780.750.500.310.27
Non-Current Assets
Property, Plant & Equipment (Net)0.020.020.020.020.030.020.01
Intangible Assets0.000.000.000.000.000.000.00
Other Non-Current Assets0.010.000.000.000.000.000.02
Total Non-Current Assets0.170.240.320.380.060.080.07
Total Assets0.350.471.101.130.560.400.33
Current Liabilities
Accounts Payable0.000.010.020.000.030.040.03
Short-Term Debt0.000.200.000.120.000.000.00
Current Portion of Long-Term Debt0.000.200.000.120.000.000.00
Accrued Liabilities0.010.050.010.020.020.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.000.010.010.000.010.020.03
Total Current Liabilities0.040.280.030.160.030.040.12
Non-Current Liabilities
Long-Term Debt0.580.500.410.340.450.430.37
Other Non-Current Liabilities0.020.030.010.000.000.030.00
Total Non-Current Liabilities0.610.560.420.360.470.460.41
Total Liabilities0.650.820.450.520.500.500.53
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.70-1.70-0.70-0.94-1.47-1.57-1.59
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.401.361.351.541.531.481.39
Shares Outstanding0.160.160.150.160.000.000.00
Total Stockholders' Equity-0.30-0.350.650.610.06-0.09-0.20
Total Liabilities & Equity0.350.471.101.130.560.400.33